Levosimendan in cardiac amyloidosis: Unveiling promising paths

Int J Cardiol. 2024 Jul 1:406:131994. doi: 10.1016/j.ijcard.2024.131994. Epub 2024 Apr 2.
No abstract available

Publication types

  • Letter
  • Editorial

MeSH terms

  • Amyloidosis* / drug therapy
  • Cardiomyopathies / drug therapy
  • Cardiotonic Agents / therapeutic use
  • Humans
  • Simendan* / therapeutic use

Substances

  • Simendan
  • Cardiotonic Agents